SOHINI NAIK: Open Payments
NPI 1457012619 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 30 payments from 21 companies in 2025. Trend: 2023 $327 · 2024 $541 · 2025 $762
Food & beverage: $662Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $182 |
| Daiichi Sankyo Inc. | 4 | $78 |
| Novocure Inc. | 2 | $46 |
| Caris MPI, Inc. | 1 | $44 |
| Aveo Pharmaceuticals, Inc. | 2 | $36 |
| Genentech USA, Inc. | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Incyte Corporation | 2 | $30 |
| GENZYME CORPORATION | 1 | $29 |
| Eisai Inc. | 1 | $25 |
Products named: ERLEADA, Optune Lua (NovoTTF-200T), MI CANCER SEEK, FOTIVDA, TECVAYLI, Venclexta, Enhertu, SARCLISA.
Industry payments across MI — which companies pay providers there.
